LIUM (SN51) is trading at $29.51, up 5.96% over 24 hours and 7.88% over seven days. It is currently at its reported 24-hour high, indicating strong recent buying pressure, though that strength also leaves the price extended relative to the day’s low of $27.31.

All five hourly moving averages are below the current price: the 8-hour SMA is $29.19, the 13-hour is $28.79, the 21-hour is $28.38, the 55-hour is $27.92, and the 144-hour is $28.50. This supports a bullish short-term reading, although the averages are not in a fully ascending sequence because the 144-hour average is above the 55-hour average.

The 1-hour RSI of 94 is an important counter-signal: it shows very strong hourly momentum but also an exceptionally overbought reading, which raises the risk of a near-term pause or pullback. The 7-day RSI at 51 is much more neutral, so the broader weekly momentum does not show the same degree of overheating.

Performance across timeframes is mixed beneath the recent advance. The 30-day gain of 26.19% is strong, but the 14-day change is only 0.22%, suggesting that gains have not been consistent throughout the past two weeks.

Reported 24-hour volume is 1,129,532, and volume is 0.79% of market capitalization. Without prior volume data for comparison, these figures do not establish whether the latest price rise has stronger-than-usual participation, limiting confirmation of the bullish move.

The 24-hour range is $2.20, from $27.31 to $29.51, and the price is at the upper endpoint. LIUM remains $7.60, or about 20.5%, below its $37.11 all-time high; that indicates room below the previous peak but does not by itself establish a likely path toward it.

Taken together, price gains and the position above all listed moving averages favor the bulls, while the 1-hour RSI of 94 argues against assuming that the advance can continue at its recent pace. The nearly flat 14-day performance and lack of comparative volume evidence also temper confidence in the strength and persistence of the move.

The overall rating is Hold. The primary evidence is bullish recent price action and price above every supplied moving average, balanced against an extremely overbought hourly RSI and uneven two-week momentum; this supports waiting for clearer confirmation rather than a decisive Buy or Sell.